Lower Limb Endovascular Therapies Symposium 2025: A Meeting of Medical Excellence in Manchester

The Lower Limb Endovascular Symposium (LLES) 2025 is one of the key events of the year in vascular medicine. It will take place on 9–10 October 2025 at the Manchester Edwardian Hotel. This international meeting brings together leading experts in lower-limb endovascular therapies. It offers a focused platform for sharing knowledge, showcasing innovative techniques, and reviewing advances in the treatment of vascular disease.

Objectives and philosophy

The main goal is to bring together experts and clinicians who want to develop and refine their lower-limb endovascular practice. The programme focuses on current evidence, common practical approaches, and rescue strategies. In addition, it aims to stimulate scientific debate and guide the future direction of lower-limb endovascular therapies.

The meeting follows a simple idea: effective learning comes from direct exchange between experienced professionals. Consequently, the format encourages networking and interdisciplinary collaboration.

Academic structure and scientific programme

Day 1 — Deep Venous Therapies

The first day is dedicated to deep venous therapies, covering both acute and chronic DVT. In the morning, sessions address the cost-effectiveness of DVT interventions, updates from the EVeR registry, and ongoing clinical trials. There are also debates on best practice in acute DVT.

One of the highlights is the lecture by Dr Marta Ramírez Ortega, internationally recognised for her expertise in deep venous thrombosis. She has been invited for her global reputation as a specialist surgeon. Her keynote, “My approach to Stenting in Acute DVT – tips and tricks,” will share advanced techniques and innovative strategies for the endovascular treatment of acute DVT.

In the afternoon, the focus shifts to chronic DVT pathways. Topics include inferior vena cava reconstruction and special scenarios such as nutcracker syndrome, venous thoracic outlet syndrome, and pulmonary embolism thrombectomy. Multiple panel discussions promote direct exchange between speakers and attendees.

Day 2 — Peripheral Arterial Therapies

The second day concentrates on peripheral arterial therapies. It starts with a research session that reviews pivotal trials — BASIL-2, BASIL-3, BEST-CLI, and SWEDEPAD. From there, the programme moves from aorto-iliac disease to advanced techniques for femoropopliteal disease.

Sessions cover algorithms for treating the common femoral artery, drug-delivery technologies, atherectomy and thrombectomy devices, and techniques for chronic total occlusions. Finally, the day closes with CLTI, infrapopliteal disease, and percutaneous venous arterialisation.

Top-tier international faculty

More than 40 international experts will participate. Notable speakers include:

• Dr Efthymios (Makis) Avgerinos (Greece) — Professor and Co-Director of Vascular Surgery

• Dr Olivier Hartung (France) — Vascular Surgeon

• Prof. Dr Mert Dumantepe (Turkey) — Professor of Cardiovascular Surgery, Üsküdar University

• Dr Mohammad E. Barbati (Germany) — Vascular and Endovascular Specialist

• Prof. Athanasios Saratzis (Leicester, UK) — Academic Vascular Surgeon

• Dr Marta Ramírez Ortega (Spain) — Chief of Vascular and Endovascular Surgery

This geographical diversity ensures a global perspective on best practice and innovative techniques.

Relevance for the Spanish medical community

The invitation to Dr Marta Ramírez Ortega is a strong recognition of the excellence of Spanish vascular surgery. Her presence highlights the quality of Spanish vascular medicine. Moreover, it offers the national community direct access to the knowledge of a specialist recognised worldwide.

Industry support and technological innovation

The event has strong backing from the medical industry, organised into Platinum, Gold, Silver, and Bronze sponsorship levels. This support helps ensure technical quality. It also provides access to the latest technologies and equipment in the endovascular field.

Educational format

A distinctive feature of LLES 2025 is its case-based discussion and interactive debate. The programme includes several panel discussions that allow direct interaction between speakers and attendees. As a result, learning is practical and specific questions can be resolved.

Sessions also include hybrid techniques, new devices, and multimodal approaches for complex vascular disease. The format combines keynote talks with practical sessions so that attendees gain both theory and immediate clinical applicability.

Impact on clinical practice

Feedback from previous editions underlines the immediate practical value of the meeting: “Excellent topics covering all PAD from aorta to the pedal arch!” and “An excellent meeting, well organised, with an excellent calibre of speakers.”These comments show its capacity to address the full spectrum of peripheral arterial disease.

Advances in mechanical thrombectomy devices

One session focuses on mechanical thrombectomy in acute DVT, including Inari ClotTriever, Aspirex, Penumbra, and AngioJet. Through case-based discussion, attendees can understand device-specific indications and optimal techniques.

Future perspectives and research

The symposium also dedicates time to emerging research and ongoing trials. Topics include robotics in vascular surgery, advances in diabetic foot disease, and new directions in vascular research. In addition, subjects such as artificial intelligence in venous disease and bioresorbable vascular scaffolds reflect the commitment to scientific innovation.

Logistics and location

The Manchester Edwardian Hotel, located in Free Trade Hall, Peter St, Manchester M2 5GP, provides an elegant and professional setting. Its central location offers excellent transport connections for national and international attendees.

Conclusion

LLES 2025 stands out as an essential event for professionals involved in lower-limb endovascular care. The combination of a top-tier international faculty — including Dr Marta Ramírez Ortega — a comprehensive scientific programme, and an innovative educational format makes this symposium a unique opportunity for professional development and progress in endovascular practice.

The two-day structure allows an in-depth focus on both venous and arterial therapies. Consequently, attendees gain a complete and up-to-date view of current practice and future trends in lower-limb endovascular therapies.